对治疗耐药抑郁症扩大对胺的获取影响分析
Thanh Lu1, Sophia D'Angelo1, Zohra Tayebali1
1RTI International, Research Triangle Park, NC 27709, USA.
Journal of comparative effectiveness research
|May 22, 2025
概括
扩大对治疗耐药抑郁症 (TRD) 胺的获取提供了显著的社会节省. 胺可能与电疗法 (ECT) 一样有效,为患者,付款人和社会提供经济利益.
科学领域:
- 精神病学是一个精神病学.
- 卫生经济学 卫生经济学
- 药物经济学 药物经济学
背景情况:
- 耐治疗抑郁症 (TRD) 影响着大量患者群体.
- 电疗法 (ECT) 是一种已确立的严重抑郁症治疗方法.
- 静脉注射胺是TRD的新兴治疗选择.
研究的目的:
- 为了估计扩大对美国TRD患者的静脉胺扩大接入的经济影响,与ECT相比.
- 从多个角度 (患者,护理人员,付款人,社会) 来评估胺与ECT的成本效益.
主要方法:
- 在5年的时间范围内使用了人口级别的马尔科夫模拟模型.
- 关键参数来自一个随机试验,比较胺和ECT.
- 经济影响包括直接的医疗保健成本和失去时间的间接成本.
主要成果:
- 扩大胺的获取可以在第一年治疗额外的75,000名患者,然后每年治疗4292名患者.
- 预计在5年内,胺的使用将带来每年828220万美元的社会净储蓄.
- 胺的使用可能会使护理人员的时间负担每年增加1080万美元.
结论:
- 胺可能是ECT的非劣质治疗,用于改善TRD患者的抑郁症状.
- 预计扩大对胺治疗的准入将为患者,付款人和社会带来净经济节省.
- 经济评估支持扩大对胺的使用,以管理TRD.
相关概念视频
Electroconvulsive Therapy
21
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
21
Antidepressant Drugs: MAOIs and Other Agents
174
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
174


